Package 42291-972-01

Brand: valganciclovir hydrochloride for oral

Generic: valganciclovir hydrochloride
NDC Package

Package Facts

Identity

Package NDC 42291-972-01
Digits Only 4229197201
Product NDC 42291-972
Product ID 42291-972_48c2d3e0-cf43-2438-e063-6294a90a9557
Description

100 mL in 1 BOTTLE (42291-972-01)

Marketing

Marketing Status
Marketed Since 2023-10-17
Brand valganciclovir hydrochloride for oral
Generic valganciclovir hydrochloride
Sample Package No

Linked Drug Pages (1)

Valganciclovir hydrochloride for Oral ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "48c2d3e0-cf43-2438-e063-6294a90a9557", "openfda": {"unii": ["4P3T9QF9NZ"], "rxcui": ["863559"], "spl_set_id": ["07eb5abf-2322-4fb9-e063-6394a90a2311"], "manufacturer_name": ["AvKARE"]}, "finished": true, "packaging": [{"sample": false, "description": "100 mL in 1 BOTTLE (42291-972-01)", "package_ndc": "42291-972-01", "marketing_start_date": "20231017"}], "brand_name": "Valganciclovir hydrochloride for Oral", "product_id": "42291-972_48c2d3e0-cf43-2438-e063-6294a90a9557", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "DNA Polymerase Inhibitors [MoA]", "Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "42291-972", "generic_name": "Valganciclovir hydrochloride", "labeler_name": "AvKARE", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Valganciclovir hydrochloride for Oral", "active_ingredients": [{"name": "VALGANCICLOVIR HYDROCHLORIDE", "strength": "50 mg/mL"}], "application_number": "ANDA205220", "marketing_category": "ANDA", "marketing_start_date": "20231017", "listing_expiration_date": "20271231"}